A carregar...
Uterine leiomyosarcoma well-controlled with eribulin mesylate
Uterine leiomyosarcoma is a rare type of malignant gynecological tumor and has a poor prognosis; therefore, this tumor is often difficult to treat. Some new drugs have been approved during the past several years in Japan and are expected to be efficacious. Eribulin, one of these drugs, is a natural...
Na minha lista:
| Publicado no: | Int Cancer Conf J |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Japan
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6498297/ https://ncbi.nlm.nih.gov/pubmed/31149544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-018-0350-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|